Objective: To determine the risk of stroke in anticoagulated patients with atrial fibrillation (AF) when anticoagulation is adjusted for bronchoscopy, gastroscopy, or colonoscopy, and to identify factors that could modify this risk. Methods: The authors reviewed patients with AF undergoing endoscopies between 1995 and 2001, with specific analysis of patients with AF in whom anticoagulation was adjusted for the procedures. The authors calculated the stroke rate within 30 days of the procedures. Results: Twelve strokes occurred in 987 patients undergoing 1,137 procedures (1.06%/procedure). The risk ranged from 0.31% for patients with nonvalvular AF undergoing routine procedures to 2.93% for complex patients undergoing endoscopies combined with other procedures or with comorbid illnesses. Patients with stroke were more likely to be complex (7/12 vs 219/975, p ϭ 0.04); to be older than 80 years (6/12 vs 187/975, p ϭ 0.017); to have a history of stroke (7/12 vs 194/975, p ϭ 0.004), hypertension (10/12 vs 508/975, p ϭ 0.04), or hyperlipidemia (9/12 vs 334/975, p ϭ 0.005); or to have a family history of vascular disease (10/12 vs 502/975, p ϭ 0.039). Conclusions: The risk of stroke in patients with AF whose anticoagulation is adjusted for endoscopies is low, but almost tenfold higher in patients with complex clinical situations. Age, history of stroke, hypertension, hyperlipidemia, and family history of vascular disease may increase the risk of stroke.
It is not known whether patients with atrial fibrillation (AF) should be kept on anticoagulation during diagnostic procedures. When anticoagulation is adjusted, the risk of ischemic stroke during the period of subtherapeutic anticoagulation is not defined. Guidelines 1 have been proposed assuming that the periprocedural period risk is the same as any other similar time without anticoagulation. The annual stroke risk for patients with nonvalvular AF varies from 1 to 20% 2 and is influenced by the following risk factors: history of stroke, hypertension, and diabetes. Assuming a 4-to 6-day period of subtherapeutic anticoagulation, the theoretical risk of stroke is estimated to be between 0.012 and 0.3%. 1 There are few data on the actual risk of stroke in this situation.
We studied the risk of stroke in patients with AF who had anticoagulation temporarily adjusted for endoscopy. This was compared to the risk in and characteristics of patients in whom anticoagulation was continued without adjustment. We examined factors that might influence this risk.
Methods. Using International Classification of Diseases-9 codes, the Mayo Clinic medical records linkage system was used to identify a population of patients undergoing bronchoscopy (11,748), colonoscopy and allied procedures (73,799), and gastroscopy (80,007) between 1995 and 2001. These 165,554 patients were then cross referenced with AF, resulting in 5,931 matches. A separate linkage was made with all codes for stroke, identifying 4,278 matches. The medical records of these matches were then examined for patients with a documented stroke and for patients with AF who had anticoagulation adjusted for endoscopic procedures. Patients with AF in whom anticoagulation was not adjusted were also analyzed.
Selection of patients with AF with adjusted anticoagulation. Patients had a documented history of AF, with anticoagulation for at least 2 weeks, evidence of adjusted anticoagulation (including withholding, reversal, or changing dose for the endoscopy with confirmation by international normalized ratio [INR]), and minimum follow-up for 30 days.
Exclusion criteria were age Ͻ18 years, anticoagulation discontinued for more than 2 weeks before or 2 weeks after the procedure, primarily therapeutic endoscopy (to avoid including patients with stroke who received gastrostomy tubes), and complex congenital cardiac lesions (e.g., tetralogy of Fallot).
Patients with AF without adjusted anticoagulation were selected in an identical fashion, except that anticoagulation was not adjusted for the procedures.
Collection of data. The following data were extracted: sex and age; vascular risk factors-smoking status (current, former, never), hypertension, diabetes, hyperlipidemia, or family history of vascular disease (cardiac, cerebrovascular, or peripheral vascular disease in a first-degree relative older than 18 years); cardiac valve pathology, including mechanical, biosynthetic, stenotic, or regurgitant valves; prior stroke or TIA; anticoagulant and antiplatelet medications in the periprocedural period; number of days before and after the procedure that oral anticoagulants were withheld; use of heparin; lowest INR on the day before, day of, or day after the procedure; type of endoscopy-bronchoscopy, gastroscopy, or colonoscopy; indication for endoscopy-elective or urgent, the latter being patients when presenting symptoms (e.g., bleeding, pain) requiring emergency hospitalization and prompting endoscopy.
Patient categorization. Patients were then categorized into two broad categories, each with two subgroups, to reflect typical clinical situations.
AF and cardiac valve lesions. Subgroup 1 included patients with mechanical cardiac valves. Subgroup 2 included patients with biosynthetic or tissue valves, valve repairs, or stenotic or regurgitant lesions. Nonvalvular AF. Subgroup 3 included routine patients who electively underwent one or more endoscopic procedures at a single session, including patients admitted to hospital electively for periprocedural management of anticoagulation.
Subgroup 4 included complex patients, patients who underwent urgent endoscopy, patients undergoing endoscopy during hospital admissions with multiple medical problems (not necessarily those prompting the endoscopy), and patients who had endoscopies and then surgery or another procedure during the period of anticoagulant manipulation.
Selection of patients with stroke. The records of all patients with the diagnosis of stroke (4, 278) and the patients with AF with (987) and without (438) adjusted anticoagulation were then reviewed for the diagnosis of stroke occurring up to 30 days after the endoscopy. Records were examined for time of stroke in relation to endoscopy, nature of the stroke symptoms, INR at the time, neurovascular imaging findings (CT, MRI, carotid Doppler), stroke treatment, and outcome (modified Rankin Score [mRS] 3 ).
Statistical analysis. The risk of stroke was calculated in the entire population undergoing endoscopies and in the patients with AF with and without adjusted anticoagulation. In the AF group, the characteristics of patients with and without stroke were compared with respect to continuous variables using two-sample t-tests and with respect to categorical features using Fisher exact tests. The characteristics of patients without adjustment of anticoagulation were compared with the adjusted anticoagulation group, using t-tests and 2 tests as appropriate.
Results. Total endoscopy and AF population. The total patients undergoing endoscopy and the derivation of the selected population of patients with AF is shown in the figure. In 26 patients, analysis was impossible owing to missing chart (1), lack of consent for record review (1), and insufficient documentation (24). In 329 patients, AF developed at a time after the endoscopy. We excluded 4,588 patients: 3,924 were either not anticoagulated or had anticoagulation withheld for more than 2 weeks before or after the endoscopy; 132 had therapeutic (rather than diagnostic) procedures, such as bronchoscopy to suction secretions, percutaneous gastrostomy insertion, or colonoscopic bowel decompression; 42 had anticoagulation discontinued indefinitely after the endoscopy (including 12 with follow-up for less than 30 days); 43 did not have 30 days of follow-up; and 9 had complex congenital heart disease. This left 987 patients in whom anticoagulation for AF was adjusted for endoscopic procedures. There were 438 patients in whom anticoagulation was not adjusted for the procedures.
Among the patients with AF with adjusted anticoagulation, there were 1,137 procedures: 588 colonoscopies, 227 gastroscopies, 110 bronchoscopies, 210 combined gastroscopies and colonoscopies, 1 combined colonoscopy and bronchoscopy, and 1 combination of all three procedures. In the patients without adjusted anticoagulation, there were 457 procedures: 217 gastroscopies, 168 colonoscopies, 43 combined gastroscopies and colonoscopies, and 29 bronchoscopies.
Stroke risk rates. Stroke risk for the total population and the patients with AF is presented in table 1. The risk of stroke occurring in the 30 days after one of these endoscopic procedures was 37/165,554 ϭ 0.02%, or 28/165,554 ϭ 0.017% up to 7 days. These numbers include the 12 patients with stroke from the AF group. There were no strokes in the patients with AF where anticoagulation was not adjusted. In patients with AF with adjusted anticoagulation, the overall 30-day risk was 12/1,137 (1.06%), but varied according to the classification. Routine patients were at lowest risk, 2/638 (0.31%), and complex at highest risk, 7/228 (2.93%). Patients with AF and cardiac valve lesions were at intermediate risk, 3/260 (1.15%). The overall 7 day per procedure risk was 9/1,137 (0.79%).
Patient characteristics and categorization. The characteristics of the patients with AF with and without adjustment of anticoagulation are shown in table 2. The two groups were similar in age, sex, and history of stroke. Vascular risk factors were more common in the adjusted group, with more patients having a family history of vascular disease, and more being former smokers. There were also differences in patient categorization, with more patients in the adjusted group being complex. Additionally, more of the adjusted group were also taking antiplatelet medications. The adjusted group had a significantly lower mean INR (1.3 vs 2.1, p Ͻ 0.001).
Comparison of patients with and without stroke. The characteristics of the patients with AF with and without postprocedural ischemic strokes are shown in table 3, and the details of the 12 patients with stroke are described below. Comparison of characteristics is between those patients in whom anticoagulation was adjusted who did have a stroke and those who did not have a stroke.
Significantly different features were age greater than 80, history of stroke, hypertension, hyperlipidemia, and family history of vascular disease. All the strokes were ischemic. Four patients underwent two separate endoscopies with adjusted anticoagulation within 30 days. The median time from endoscopic procedure to stroke was 9.5 days (range 1 to 30 days) when only the first procedure was considered or 3 days where a second procedure was implicated. Two patients had a second stroke in relation to the second endoscopy, but these were not counted as separate strokes for purposes of calculating the rates.
Nine of the 12 patients with stroke had neuroimaging (6, MRI; 3, CT) confirming cortical infarcts suggestive of embolism. Two patients had CT scans showing old changes but had clinical signs suggesting cortical involvement. One patient initially had a monoparesis and a CT scan showing small vessel ischemic changes but later had a fatal hemispheric stroke. One patient had an infarction confirmed at autopsy.
Eight of the patients with stroke had carotid vascular studies, and only one had significant carotid stenosis, which could have been the stroke mechanism instead of AF. Two of the four patients without carotid studies had confirmed posterior cerebral artery infarcts.
Five patients had no significant disability or symptoms (mRS ϭ 0 or 1), four died within 3 months, and, of the remaining three, there was one in each category of disabil-ity-moderate, moderate to severe, and severe (mRS 3, 4, and 5).
Discussion. We studied the stroke risk in a large population of patients undergoing endoscopic procedures. We specifically calculated the stroke risk among patients with AF in whom anticoagulation was adjusted for endoscopic procedures and identified factors that may increase the risk of stroke. No strokes occurred in patients with AF in whom anticoagulation was not adjusted. Our study substantially increases the available data regarding the periprocedural management of patients receiving oral anticoagulants by increasing more than 50% the number of patients reported 4 and adding more stroke events than all previous reports combined. 5 A recent review 5 of the English language literature identified 31 reports of 1,868 patients anticoagulated for various indications and procedures. Overall, there were 29 thromboembolic events, including 7 strokes. As in our study, the authors 5 note that the periprocedural thromboembolic event rates (1.6% overall, and 0.4% for stroke) were higher than that predicted by a theoretical mathematical model. 1 The 30-day stroke risk in the total population undergoing endoscopy was exceedingly low at 0.02%. This compares with the 0.08% stroke risk observed in 24,641 patients up to 36 days after general and vascular surgery. 6 In our specific subpopulation of patients with AF and adjusted anticoagulation, we found that the risk of stroke was 1.06%. This is higher than that predicted by theoretical calculations 1 and the baseline risk in the total population undergoing endoscopy. The risk for routine patients with nonvalvular AF was comparable to the upper limit of that predicted by the theoretical models. 1 None of the 110 patients undergoing bronchoscopy developed a stroke. If the study had been limited to gastrointestinal endoscopies then the rate would have been somewhat higher (12/1,027 or 1.17%). The 30-day time window was chosen because this is commonly used in studies of periprocedural stroke. If the time window was 6 days (to match that set in the theoretical model 1 ), then 9 strokes would have been recorded, resulting in a rate of 9/1,137 ϭ 0.79%. Thus, depending upon the type of endoscopy population and time window, the overall risk of stroke could be as low as 0.79%, and as high as 1.17%. The 26 patients with incomplete data and 43 with incomplete follow-up represent a shortcoming of the study and reduce the accuracy of the observed rate. It is possible that strokes occurred in this subset of patients, but it would represent a small fraction of the population studied. It is notable that a large percentage of the patients with AF (3,925/5,931 [66.2%]) were not anticoagulated. Presumably many patients in this population would be poor candidates for anticoagulation because of the accompanying illness that led to the performance of endoscopies.
Our study population has some differences com-pared to the pooled data 2 from five studies of antithrombotic therapy for AF upon which the theoretical risks 1 of periprocedural anticoagulation adjustment were based. The mean age of patients in these studies 2 was 69 years, compared with 77.3 in our patients with stroke and 73.2 in endoscopy patients without a stroke. Because age is an independent risk factor for stroke, 7 this might partly explain the higher risk in our study. In these studies, hypertension, diabetes, and prior history of stroke or TIA were seen in 46%, 6%, and 14% of the AF population, 2 and these factors increased the stroke risk. Comparable percentages in the patients without stroke in our study were 52%, 17%, and 20%. We found hypertension and prior stroke history, along with hyperlipidemia and a family history of vascular disease, to be associated with increased risk for periprocedural stroke, whereas diabetes was not. Prior history of stroke has also been noted as a risk for stroke after general surgery. 4 We compared the characteristics of our patients with AF in whom anticoagulation was adjusted with those where it was not. The group with adjusted anticoagulation had more vascular risk factors, and more complex cases. This might suggest that patient characteristics are a major factor contributing to the increased stroke risk, along with the effect of adjusting anticoagulation. It is likely that the patient classification as complex was the predominant factor, rather than the effect of smoking status or family history of vascular disease.
Other factors may influence periprocedural stroke risk. There is evidence that discontinuation of oral anticoagulants may lead to a rebound increase in clotting factors. 8 Additionally, prior theoretical models do not account for the potential thrombogenic milieu that accompanies infectious and inflammatory illnesses and general surgery, 9, 10 which may account for increased stroke risk. This may partly explain increased risk among complex patients who were categorized as such because of accompanying illnesses.
The limited statistical power of our study limits conclusions regarding factors that were not statistically significant, particularly the use of heparin. Only one of the patients with stroke (8%) was given periprocedural heparin, compared with 297 (30%) of the patients without stroke.
When stroke occurred in this setting, it was associated with major handicap. Half the patients with stroke eventually died or remained moderately to severely disabled. The poor outcome is probably due to the large cortical strokes, advanced age (mean 77.3 years), and comorbid illnesses.
Although the overall stroke risk per procedure in this setting is low (from 0.79 to 1.17%), clearly this is a common clinical dilemma-a decision on management was required on 1,425 patients, 1,594 times in a 6-year period at a single institution. Our risk calculations might be used to counsel patients when endoscopic procedures are planned. Considering that the sequelae of stroke in these patients were significant (50% dead or moderate disability), clinicians should consider continuing anticoagulation where possible or taking great care with periprocedural management, particularly in patients with features predicting increased risk for stroke.
